Waddell & Reed Financial (WDR) - FREE Research Report Sanders Philip James who is SVP & Chief Investment Officer at Waddell & Reed Financial sold 13,000 shares at $63.72 on Nov. 12, 2013. Following this transaction, the SVP & Chief Investment Officer owned 229,261 shares meaning that the stake was reduced by 5.37% with the 13,000 share transaction. The shares most recently traded at $63.61, down $0.11, or 0.18% since the insider transaction. Historical insider transactions for Waddell & Reed Financial go as follows:
12-Week # shares sold: 10,000
24-Week # shares bought: 61
24-Week # shares sold: 36,540
The average volume for Waddell & Reed Financial has been 635,100 shares per day over the past 30 days. Waddell & Reed Financial has a market cap of $5.5 billion and is part of the financial sector and financial services industry. Shares are up 84.46% year to date as of the close of trading on Tuesday. Waddell & Reed Financial, Inc., through its subsidiaries, provides investment management, investment product underwriting and distribution, and shareholder services administration to mutual funds, and institutional and separately managed accounts in the United States. The stock currently has a dividend yield of 1.74%. The company has a P/E ratio of 24.2. Currently there are 2 analysts that rate Waddell & Reed Financial a buy, 1 analyst rates it a sell, and 6 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on WDR - FREETheStreet Quant Ratings rates Waddell & Reed Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Waddell & Reed Financial Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.